The gating strategy for a patient with high and low B7-H3 expression is shown in Figure 1A. The percentage of B7-H3-positive cells varied widely, ranging from 0.1% to 99.9% with a mean of 32.6% of all AML blasts (Figure 1B). Here, CD276 is linked to acute myeloid leukemia.